FDA's plan for issuing the patient-focused drug development guidance documents required under the 21st Century Cures Act includes numerous public workshops and a slightly more aggressive timeframe for some draft guidances than required under the pending agreement to reauthorize the Prescription Drug User Fee Act (PDUFA VI).
In total, the schedule FDA lays out in its "Plan for Issuance of Patient-Focused Drug Development Guidance Under 21st Century...







